Magnus Åstrand

Magnus Åstrand

AstraZeneca, Sweden - Södertälje / Sweden
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 4403168
-
person_outline Magnus Åstrand's MOST POPULAR ARTICLES
1-) A comparison of normalization methods for high density oligonucleotide array data based on variance and biasBM Bolstad, RA Irizarry, M Åstrand, TP SpeedBioinformatics 19 (2), 185-193, 200394432003
2-) Randomised clinical trial: the efficacy of a transient receptor potential vanilloid 1 antagonist AZD1386 in human oesophageal painAL Krarup, L Ny, M Åstrand, A Bajor, F Hvid‐Jensen, MB Hansen, ...Alimentary pharmacology & therapeutics 33 (10), 1113-1122, 20111322011
3-) Effect of tenapanor on serum phosphate in patients receiving hemodialysisGA Block, DP Rosenbaum, M Leonsson-Zachrisson, M Åstrand, ...Journal of the American Society of Nephrology 28 (6), 1933-1942, 20171082017
4-) Contrast normalization of oligonucleotide arraysM ÅstrandJournal of Computational Biology 10 (1), 95-102, 20031092003
5-) Zibotentan in combination with dapagliflozin compared with dapagliflozin in patients with chronic kidney disease (ZENITH-CKD): a multicentre, randomised, active-controlled …HJL Heerspink, A Kiyosue, DC Wheeler, M Lin, E Wijkmark, G Carlson, ...The Lancet 402 (10416), 2004-2017, 2023642023